332 related articles for article (PubMed ID: 23661553)
21. Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Cancer Res; 2007 May; 67(10):4869-77. PubMed ID: 17495323
[TBL] [Abstract][Full Text] [Related]
22. TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms.
Angelov SN; Hu JH; Wei H; Airhart N; Shi M; Dichek DA
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2102-2113. PubMed ID: 28729364
[TBL] [Abstract][Full Text] [Related]
23. TGFβ signaling limits lineage plasticity in prostate cancer.
Hao Y; Bjerke GA; Pietrzak K; Melhuish TA; Han Y; Turner SD; Frierson HF; Wotton D
PLoS Genet; 2018 May; 14(5):e1007409. PubMed ID: 29782499
[TBL] [Abstract][Full Text] [Related]
24. TGFβ signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions.
Shaw AK; Pickup MW; Chytil A; Aakre M; Owens P; Moses HL; Novitskiy SV
PLoS One; 2015; 10(1):e0117908. PubMed ID: 25629162
[TBL] [Abstract][Full Text] [Related]
25. TGF-β-responsive myeloid cells suppress type 2 immunity and emphysematous pathology after hookworm infection.
Heitmann L; Rani R; Dawson L; Perkins C; Yang Y; Downey J; Hölscher C; Herbert DR
Am J Pathol; 2012 Sep; 181(3):897-906. PubMed ID: 22901754
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
Wendt MK; Schiemann WP
Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433
[TBL] [Abstract][Full Text] [Related]
28. Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis.
Li X; Placencio V; Iturregui JM; Uwamariya C; Sharif-Afshar AR; Koyama T; Hayward SW; Bhowmick NA
Oncogene; 2008 Nov; 27(56):7118-30. PubMed ID: 18724388
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy.
Romero-Gallo J; Sozmen EG; Chytil A; Russell WE; Whitehead R; Parks WT; Holdren MS; Her MF; Gautam S; Magnuson M; Moses HL; Grady WM
Oncogene; 2005 Apr; 24(18):3028-41. PubMed ID: 15735717
[TBL] [Abstract][Full Text] [Related]
30. Role of T cell TGF-beta signaling in intestinal cytokine responses and helminthic immune modulation.
Ince MN; Elliott DE; Setiawan T; Metwali A; Blum A; Chen HL; Urban JF; Flavell RA; Weinstock JV
Eur J Immunol; 2009 Jul; 39(7):1870-8. PubMed ID: 19544487
[TBL] [Abstract][Full Text] [Related]
31. USP8 promotes cancer progression and extracellular vesicle-mediated CD8+ T cell exhaustion by deubiquitinating the TGF-β receptor TβRII.
Xie F; Zhou X; Li H; Su P; Liu S; Li R; Zou J; Wei X; Pan C; Zhang Z; Zheng M; Liu Z; Meng X; Ovaa H; Ten Dijke P; Zhou F; Zhang L
EMBO J; 2022 Aug; 41(16):e108791. PubMed ID: 35811497
[TBL] [Abstract][Full Text] [Related]
32. Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-β type II receptor.
Borczuk AC; Sole M; Lu P; Chen J; Wilgus ML; Friedman RA; Albelda SM; Powell CA
Cancer Res; 2011 Nov; 71(21):6665-75. PubMed ID: 21911454
[TBL] [Abstract][Full Text] [Related]
33. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.
Ijichi H; Chytil A; Gorska AE; Aakre ME; Fujitani Y; Fujitani S; Wright CV; Moses HL
Genes Dev; 2006 Nov; 20(22):3147-60. PubMed ID: 17114585
[TBL] [Abstract][Full Text] [Related]
34. AKT hyperactivation confers a Th1 phenotype in thymic Treg cells deficient in TGF-β receptor II signaling.
Liu Y; Xu Y; Sun J; Ma A; Zhang F; Xia S; Xu G; Liu Y
Eur J Immunol; 2014 Feb; 44(2):521-32. PubMed ID: 24165986
[TBL] [Abstract][Full Text] [Related]
35. Loss of TGF-β signaling in osteoblasts increases basic-FGF and promotes prostate cancer bone metastasis.
Meng X; Vander Ark A; Daft P; Woodford E; Wang J; Madaj Z; Li X
Cancer Lett; 2018 Apr; 418():109-118. PubMed ID: 29337106
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth.
Daly AC; Randall RA; Hill CS
Mol Cell Biol; 2008 Nov; 28(22):6889-902. PubMed ID: 18794361
[TBL] [Abstract][Full Text] [Related]
37. TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms.
Novitskiy SV; Pickup MW; Gorska AE; Owens P; Chytil A; Aakre M; Wu H; Shyr Y; Moses HL
Cancer Discov; 2011 Oct; 1(5):430-41. PubMed ID: 22408746
[TBL] [Abstract][Full Text] [Related]
38. Modulation of noncanonical TGF-β signaling prevents cleft palate in Tgfbr2 mutant mice.
Iwata J; Hacia JG; Suzuki A; Sanchez-Lara PA; Urata M; Chai Y
J Clin Invest; 2012 Mar; 122(3):873-85. PubMed ID: 22326956
[TBL] [Abstract][Full Text] [Related]
39. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.
Yin JJ; Selander K; Chirgwin JM; Dallas M; Grubbs BG; Wieser R; Massagué J; Mundy GR; Guise TA
J Clin Invest; 1999 Jan; 103(2):197-206. PubMed ID: 9916131
[TBL] [Abstract][Full Text] [Related]
40. Defective TGF-β signaling in bone marrow-derived cells prevents hedgehog-induced skin tumors.
Fan Q; Gu D; Liu H; Yang L; Zhang X; Yoder MC; Kaplan MH; Xie J
Cancer Res; 2014 Jan; 74(2):471-483. PubMed ID: 24282281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
